Clinical trial · Observational
Effect of Hyponatremia in Small Cell Lung Cancer
Frequency and Effect on the Prognosis of Hyponatremia During the diagnosıs in Small Cell Lung Cancer
NCT04451460CI-TRIAL-00045732completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this retrospective study, the investigators determined the frequency of hyponatremia in small cell lung cancer and the prognosis. 126 (27%) of 466 patients were hyponatremic. Hyponatremia could not be corrected in 50.8% (n=64) of hyponatremic patients. Survival was found to be better in the group of whom hyponatremia was corrected.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Small Cell Lung Cancer | Lung Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Hyponatremia
- description
- Hyponatremic small cell cancer patients
- label
- Normonatremia
- description
- Normonatremic small cell cancer patients
Primary outcomes (1)
- measure
- Mortality
- timeFrame
- Through study completion, an average of 3 months
- description
- Effect of hyponatremia according to mortality
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients diagnosed with SCLC between January 2012 and January 2017 in our hospital were retrospectively screened Exclusion Criteria: Over 18 age If data doesn't exist
References
Publications (0)
Data not yet available
No reference posted for this study.